Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael K Gibson

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
Oncology (Williston Park, N.Y.)|December 15, 2010
Targeted therapy: an evolving concept in esophageal adenocarcinomaMichael K Gibson, Usha Malhotra
Current Treatment Options in Oncology|August 30, 2022
Approach to Localized Squamous Cell Cancer of the EsophagusChloe Weidenbaum, Michael K Gibson
Oncology & Hematology Review|May 24, 2019
Evolving Management Strategies for Metastatic Esophageal and Gastroesophageal Junction AdenocarcinomaSatya Das, Michael K Gibson
Current Oncology Reports|April 14, 2007
Combined-modality therapy for esophageal and gastroesophageal junction cancersHarry H Yoon, Michael K Gibson
The Lancet. Oncology|July 4, 2006
Reassessment of the role of induction chemotherapy for head and neck cancerMichael K Gibson, Arlene A Forastiere
Current Opinion in Oncology|April 8, 2004
Multidisciplinary approaches in the management of advanced head and neck tumors: state of the artMichael K Gibson, Arlene A Forastiere
Cancer Journal (Sudbury, Mass.)|September 12, 2003
Combined-modality therapy for esophageal cancer: are we making progress?Michael K Gibson, Arlene A Forastiere
Current Gastroenterology Reports|October 9, 2023
Esophageal Cancer: Overview, Risk Factors, and Reasons for the RiseSteve Lander, Eric Lander, Michael K Gibson
Nature Clinical Practice. Oncology|April 28, 2007
Chemoradiotherapy for localized esophageal cancer: regimen selection and molecular mechanisms of radiosensitizationLawrence Kleinberg, Michael K Gibson, Arlene A Forastiere
Cancers|February 10, 2024
An Ailment with Which I Will Contend: A Narrative Review of 5000 Years of Esophagogastric Cancers and Their Treatments, with Special Emphasis on Recent Advances in ImmunotherapeuticsC Beau Hilton, Steven Lander, Michael K Gibson
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
Oncology (Williston Park, N.Y.)|December 15, 2010
Targeted therapy: an evolving concept in esophageal adenocarcinomaMichael K Gibson, Usha Malhotra
Current Treatment Options in Oncology|August 30, 2022
Approach to Localized Squamous Cell Cancer of the EsophagusChloe Weidenbaum, Michael K Gibson
Oncology & Hematology Review|May 24, 2019
Evolving Management Strategies for Metastatic Esophageal and Gastroesophageal Junction AdenocarcinomaSatya Das, Michael K Gibson
Current Oncology Reports|April 14, 2007
Combined-modality therapy for esophageal and gastroesophageal junction cancersHarry H Yoon, Michael K Gibson
The Lancet. Oncology|July 4, 2006
Reassessment of the role of induction chemotherapy for head and neck cancerMichael K Gibson, Arlene A Forastiere
Current Opinion in Oncology|April 8, 2004
Multidisciplinary approaches in the management of advanced head and neck tumors: state of the artMichael K Gibson, Arlene A Forastiere
Cancer Journal (Sudbury, Mass.)|September 12, 2003
Combined-modality therapy for esophageal cancer: are we making progress?Michael K Gibson, Arlene A Forastiere
Current Gastroenterology Reports|October 9, 2023
Esophageal Cancer: Overview, Risk Factors, and Reasons for the RiseSteve Lander, Eric Lander, Michael K Gibson
Nature Clinical Practice. Oncology|April 28, 2007
Chemoradiotherapy for localized esophageal cancer: regimen selection and molecular mechanisms of radiosensitizationLawrence Kleinberg, Michael K Gibson, Arlene A Forastiere
Cancers|February 10, 2024
An Ailment with Which I Will Contend: A Narrative Review of 5000 Years of Esophagogastric Cancers and Their Treatments, with Special Emphasis on Recent Advances in ImmunotherapeuticsC Beau Hilton, Steven Lander, Michael K Gibson
Pageof 8